knowledge -WSS

knowledge

author：entertainment 2025-08-12 06:43:24 - browse：993

After months of vigorous deliberations, I’m thrilled to announce our 2023 STATUS List — the definitive roster of leaders in health, medicine, and the life sciences whose work over the past year has advanced those fields.

There were, of course, many contenders to choose from. For this second annual list, we’ve selected just 46 — an homage to the number of chromosomes in human DNA. Many are well-known as changemakers; others are largely unheralded heroes. They are CEOs, philanthropists, government officials, and health advocates. All have compelling stories to tell.

Our editorial team painstakingly researched and identified hundreds of finalists. In winnowing down the list, judges placed special emphasis on people who have sought to help others and build community in these often-divisive times. One note: Our news coverage is independent of this list, and we remain committed to tough-minded reporting on the people and institutions shaping life sciences.

While I have your attention, I want to point you to some of our most talked-about exclusive stories in recent days: A new STAT investigation exposes how Medicare Advantage plans use algorithms to cut off care for seniors in need, and we took a closer look at how a Medicare Advantage business is strangling one of its first funders. We’re aggressively reporting on the consequences for biotech of the Silicon Valley Bank collapse.

And over the coming months, in our series “The Obesity Revolution,” we’ll explore a class of obesity drugs that is transforming patients’ lives, dividing medical experts, and spurring one of the biggest business battles in years.

For full access to our exclusive reporting, please consider purchasing a STAT+ subscription. Get 15% off an annual subscription by using promo code STAT15 when you check out.

As always, please reach out to me with feedback. I’m at [email protected].

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Gritstone Bio's cancer vaccine test, and more on Novartis' deal

WSS

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Big Tobacco's 'harm reduction': Is it for real, or a sham?

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

What’s missing from the debate over nursing home staff minimums

Criminal prosecution for violating HIPAA: an emerging threat

Gene therapy for Afghan refugees’ infant will be fully covered

focus

knowledge

focus

In Memoriam: Notable people who died in 2023

340B reform proposal comes out of Senate working group

ChatGPT in medicine: STAT answers readers' burning questions

Bird flu: Don't repeat Covid's 'health versus the economy' framing

Walensky prepares to leave CDC — and Congress — behind

Readers respond to H5N1 and livestock movements, and more

Drug repurposing or repositioning? The language matters

Problems with a popular proposal to regulate AI in health care

Apple is now the first public company to be valued at $3 trillion

Adopting new red light myopia treatments may be short

hotspot

Glen Campbell's doctor discusses his public struggle with Alzheimer's

Texas Medical Board asked to define abortion emergency exception

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

AI gets buy

Adopting new red light myopia treatments may be short

Cytokinetics CEO stresses company can launch heart drug on its own

focus

focus

focus

leisure time